Qsymia, a new weight loss drug approved by the FDA earlier this year is now available through prescription. The approved indication is for patients who are obese or overweight with a BMI of 27 or greater who also suffer from co-morbidities such as hypertension and diabetes. Qsymia has two main active ingredients: topiramate, an anticonvulsant and phentermine, an appetite suppressant. Of the 4000 participants enrolled in the study, about 50% of them experienced a 10% weight loss while four-fifths lost 5% of their body weight. FDA recommends women of child bearing age to use contraception as well as a pregnancy test every month due to the birth defects associated with topiramate. What is your opinion on the safety of the recently approved diet drugs by the FDA?
For more information, please visit www.CNN.com.